- Home
- XTNT vs ZURA Comparison
XTNT vs ZURA Comparison
Compare XTNT & ZURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XTNT
- ZURA
- Stock Information
- Founded
- XTNT N/A
- ZURA 2022
- Country
- XTNT United States
- ZURA United States
- Employees
- XTNT N/A
- ZURA N/A
- Industry
- XTNT Biotechnology: Biological Products (No Diagnostic Substances)
- ZURA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- XTNT Health Care
- ZURA Health Care
- Exchange
- XTNT Nasdaq
- ZURA Nasdaq
- Market Cap
- XTNT 82.1M
- ZURA 69.9M
- IPO Year
- XTNT N/A
- ZURA N/A
- Fundamental
- Price
- XTNT $0.62
- ZURA $2.20
- Analyst Decision
- XTNT
- ZURA Buy
- Analyst Count
- XTNT 0
- ZURA 10
- Target Price
- XTNT N/A
- ZURA $12.67
- AVG Volume (30 Days)
- XTNT 91.3K
- ZURA 338.7K
- Earning Date
- XTNT 08-12-2025
- ZURA 11-06-2025
- Dividend Yield
- XTNT N/A
- ZURA N/A
- EPS Growth
- XTNT N/A
- ZURA N/A
- EPS
- XTNT N/A
- ZURA N/A
- Revenue
- XTNT $127,766,000.00
- ZURA N/A
- Revenue This Year
- XTNT $13.03
- ZURA N/A
- Revenue Next Year
- XTNT N/A
- ZURA N/A
- P/E Ratio
- XTNT N/A
- ZURA N/A
- Revenue Growth
- XTNT 15.16
- ZURA N/A
- 52 Week Low
- XTNT $0.33
- ZURA $0.97
- 52 Week High
- XTNT $0.78
- ZURA $5.07
- Technical
- Relative Strength Index (RSI)
- XTNT 49.51
- ZURA 70.63
- Support Level
- XTNT $0.59
- ZURA $1.97
- Resistance Level
- XTNT $0.65
- ZURA $2.10
- Average True Range (ATR)
- XTNT 0.04
- ZURA 0.15
- MACD
- XTNT -0.00
- ZURA 0.01
- Stochastic Oscillator
- XTNT 47.67
- ZURA 86.21
About XTNT Xtant Medical Holdings Inc.
Xtant Medical Holdings Inc is a medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. The company's biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect Plus DBM putty, OsteoWrap, and the line of 3Demin products, as well as other allografts. It generates a majority of its revenue from the U.S.
About ZURA Zura Bio Limited
Zura Bio Ltd is a clinical-stage, multi-asset immunology company developing novel dual-pathway antibodies for autoimmune and inflammatory diseases. It is developing three assets which have completed Phase I/Ib studies and are Phase II ready. It is developing a portfolio of therapeutic indications for tibulizumab and torudokimab with a goal of demonstrating their efficacy, safety, and dosing convenience in autoimmune and inflammatory diseases.